GC-MS screening conditions were developed for 15 low-dosed benzodiazepines,
covering alprazolam, flunitrazepam, flurazepam, ketazolam, lorazepam and t
riazolam, and the corresponding metabolites alpha -hydroxyalprazolam, 4-hyd
roxy-alprazolam; 7-aminoflunitrazepam, desmethylflunitrazepam, 7-aminodesme
thylflunitrazepam; hydroxyethylflurazepam, N-desalkylflurazepam; oxazepam a
nd alpha -hydroxytriazolam, respectively. Benzodiazepines are analyzed on a
polydimethylsiloxane column in both the scan and the multiple ion monitori
ng modes using on-column injection to attain maximal sensitivity. The react
ive compounds are acetylated with pyridine and acetic anhydride for 20 min.
The derivatives are stable for at least 4 days. The relative standard devi
ation observed with standard compounds at the low nanogram-level ranged fro
m 1.13 to 4.87% within-day and from 1.12 to 4.94% between-day. Unequivocal
identification potential, high chromatographic resolution and sensitivity a
re combined with minimal thermal degradation. The presented screening condi
tions provide the basis for a unique routine screening method for low-dosed
benzodiazepines with a broad polarity range. (C) 2001 Elsevier Science B.V
. All rights reserved.